國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Atlas of liquid biopsycirculating tu...

Chinen, Ludmilla Thome Domingos.

Atlas of liquid biopsycirculating tumor cells and other rare cells in cancer patients' blood /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Atlas of liquid biopsyedited by Ludmilla Thome Domingos Chinen.
其他題名:	circulating tumor cells and other rare cells in cancer patients' blood /
其他作者:	Chinen, Ludmilla Thome Domingos.
出版者:	Cham :Springer International Publishing :2021.
面頁冊數:	xii, 204 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	CytodiagnosisAtlases.
電子資源:	https://doi.org/10.1007/978-3-030-69879-9
ISBN:	9783030698799$q(electronic bk.)

Atlas of liquid biopsycirculating tumor cells and other rare cells in cancer patients' blood /
Atlas of liquid biopsycirculating tumor cells and other rare cells in cancer patients' blood /[electronic resource] :edited by Ludmilla Thome Domingos Chinen. - Cham :Springer International Publishing :2021. - xii, 204 p. :ill., digital ;24 cm.

Introduction -- Typical Circulating Tumor Cells (CTCs) -- Atypical CTCs -- Endothelial Cells -- Circulating Tumor Microemboli -- Giant Macrophages -- Cells of Undetermined Meaning.

This book provides a wealth of images and extensive information on circulating tumor cells (CTCs) and other cells usually observed in blood from patients with cancer, such as giant macrophages, and circulating tumor microemboli (CTM) The field of "liquid biopsy" began with the analysis of CTCs in the early 2000s. In the beginning, molecular techniques were developed to detect these cells in the blood. However, it has since become clear that CTCs initially require a cytopathological analysis to be detected without false positive and negative results. After detection, molecular analysis can be subsequently performed. Cancer is an important cause of mortality, especially when detected in late stages. Even with all the advances that have been made in its treatment, cancer is still challenging, as many patients do not respond to any therapy. Many health agencies have considered early diagnosis as a feasible tool. In this context, it is of the utmost importance to know the morphology and characteristics of CTCs to determine a correct diagnosis. Currently much of the scientific community is committed to expanding our knowledge of CTCs, and this work makes a valuable contribution, presenting many cell images from patients with several types of cancer, in different stages of disease, and after receiving various treatments. The Atlas of Liquid Biopsy: Circulating Tumor Cells and Other Rare Cells in Cancer Patients' Blood is an essential reference guide for all physicians, biologists, biomedics, and professionals working at hospitals, clinics and research centers.

ISBN: 9783030698799$q(electronic bk.)

Standard No.: 10.1007/978-3-030-69879-9doiSubjects--Topical Terms:

437043
Cytodiagnosis
--Atlases.

LC Class. No.: RB43 / .A85 2021

Dewey Class. No.: 616.07582

Atlas of liquid biopsycirculating tumor cells and other rare cells in cancer patients' blood /
LDR:02788nmm a2200325 a 4500 001 598874
003 DE-He213
005 20210531074514.0
006 m d
007 cr nn 008maaau
008 211025s2021 sz s 0 eng d
020 $a 9783030698799$q(electronic bk.)
020 $a 9783030698782$q(paper)
024 7 $a 10.1007/978-3-030-69879-9 $2 doi
035 $a 978-3-030-69879-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RB43 $b .A85 2021
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.07582 $2 23
090 $a RB43 $b .A881 2021
245 0 0 $a Atlas of liquid biopsy $h [electronic resource] : $b circulating tumor cells and other rare cells in cancer patients' blood / $c edited by Ludmilla Thome Domingos Chinen.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a xii, 204 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction -- Typical Circulating Tumor Cells (CTCs) -- Atypical CTCs -- Endothelial Cells -- Circulating Tumor Microemboli -- Giant Macrophages -- Cells of Undetermined Meaning.
520 $a This book provides a wealth of images and extensive information on circulating tumor cells (CTCs) and other cells usually observed in blood from patients with cancer, such as giant macrophages, and circulating tumor microemboli (CTM) The field of "liquid biopsy" began with the analysis of CTCs in the early 2000s. In the beginning, molecular techniques were developed to detect these cells in the blood. However, it has since become clear that CTCs initially require a cytopathological analysis to be detected without false positive and negative results. After detection, molecular analysis can be subsequently performed. Cancer is an important cause of mortality, especially when detected in late stages. Even with all the advances that have been made in its treatment, cancer is still challenging, as many patients do not respond to any therapy. Many health agencies have considered early diagnosis as a feasible tool. In this context, it is of the utmost importance to know the morphology and characteristics of CTCs to determine a correct diagnosis. Currently much of the scientific community is committed to expanding our knowledge of CTCs, and this work makes a valuable contribution, presenting many cell images from patients with several types of cancer, in different stages of disease, and after receiving various treatments. The Atlas of Liquid Biopsy: Circulating Tumor Cells and Other Rare Cells in Cancer Patients' Blood is an essential reference guide for all physicians, biologists, biomedics, and professionals working at hospitals, clinics and research centers.
650 0 $a Cytodiagnosis $v Atlases. $3 437043
650 0 $a Tumor markers $v Atlases. $3 892803
650 1 4 $a Oncology. $3 195181
650 2 4 $a Pathology. $3 196513
700 1 $a Chinen, Ludmilla Thome Domingos. $3 892802
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-69879-9
950 $a Medicine (SpringerNature-11650)